Variations in NIPBL protein and mRNA expression levels in four lung cancer cell lines H1299, A549, H661, and H1650 were quantitated by using the quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and western blot analysis. This evidence concerns the gene NIPBL and lung carcinoma.